These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33618945)

  • 1. Evaluation of swine protection with foot-and-mouth disease O
    Choi J; Jo HJ; Jung SS; Choi J; Lee SH; Kim HH; Kim YJ; Kim B; Park JH; Kim J
    Vaccine; 2021 Mar; 39(12):1701-1707. PubMed ID: 33618945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-protective efficacy of the O1 Manisa + O 3039 bivalent vaccine and the O 3039 monovalent vaccine against heterologous challenge with FMDV O/Jincheon/SKR/2014 in pig.
    Kim T; Hong JK; Oem JK; Lee KN; Lee HS; Kim YJ; Ryoo S; Ko YJ; Park JH; Choi J; Lee SH; Jo HJ; Lee MH; Kim B; Kim J
    Vaccine; 2019 Mar; 37(12):1702-1709. PubMed ID: 30712811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of a high quality O
    Galdo Novo S; Malirat V; Maradei ED; Pedemonte AR; Espinoza AM; Smitsaart E; Lee KN; Park JH; Bergmann IE
    Vaccine; 2018 Mar; 36(12):1570-1576. PubMed ID: 29472132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interference effect of maternally-derived antibodies on the serological performance of pigs immunized with a foot-and-mouth disease oil emulsion vaccine.
    Kim J; Kim T; Hong JK; Lee HS; Lee KN; Jo HJ; Choi J; Choi J; Lee SH; Lee MH; Kim B; Park JH
    Vaccine; 2020 Feb; 38(7):1723-1729. PubMed ID: 31892447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved foot-and-mouth disease vaccine with O PanAsia-2 strain protect pigs against O/Jincheon/SKR/2014 originated from South Korea.
    Ko MK; Jo HE; Choi JH; You SH; Shin SH; Jo H; Lee MJ; Kim SM; Kim B; Park JH
    Vaccine; 2020 Jan; 38(5):1120-1128. PubMed ID: 31810782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad immunogenic spectrum of monovalent and trivalent foot-and-mouth disease virus vaccines containing O
    Malirat V; Caldevilla C; Cardillo S; Espinoza AM; Novo SG; Taffarel A; Benito MB; Bergmann IE
    Vaccine; 2023 Sep; 41(39):5782-5790. PubMed ID: 37574343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved foot-and-mouth disease vaccine, O TWN-R, protects pigs against SEA topotype virus occurred in South Korea.
    Choi JH; Ko MK; Shin SH; You SH; Jo HE; Jo H; Lee MJ; Kim SM; Lee JS; Kim B; Park JH
    Vet Microbiol; 2019 Sep; 236():108374. PubMed ID: 31500734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New foot-and-mouth disease vaccine, O JC-R, induce complete protection to pigs against SEA topotype viruses occurred in South Korea, 2014-2015.
    Jo HE; Ko MK; Choi JH; Shin SH; Jo H; You SH; Lee MJ; Kim SM; Kim B; Park JH
    J Vet Sci; 2019 Jul; 20(4):e42. PubMed ID: 31364326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with a FMDV O Mya98 lineage virus in pigs 4 and 7 days post vaccination.
    Wilna V; Hong NT; Geoffrey FT; Jacqueline MM; Jianning W; Van Phuc K; Ngon QV; Phuong le TT; Hung D; Hanh TX; Van Hung V; Anh le TQ; Tien MT; Quang le TV; Long NT; Nagendrakumar SB
    Vaccine; 2015 Jun; 33(24):2778-85. PubMed ID: 25917677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccine strain of O/ME-SA/Ind-2001e of foot-and-mouth disease virus provides high immunogenicity and broad antigenic coverage.
    Lee G; Hwang JH; Park JH; Lee MJ; Kim B; Kim SM
    Antiviral Res; 2020 Oct; 182():104920. PubMed ID: 32828822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of a high potency O1 Manisa monovalent vaccine against heterologous challenge with foot-and-mouth disease virus of O/SEA/Mya-98 lineage in sheep.
    Singanallur NB; Pacheco JM; Arzt J; Stenfeldt C; Fosgate GT; Rodriguez L; Vosloo W
    Antiviral Res; 2017 Sep; 145():114-122. PubMed ID: 28780422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological responses after vaccination of growing pigs with foot-and-mouth disease trivalent (type O, A and Asia1) vaccine.
    Lee HS; Lee NH; Seo MG; Ko YJ; Kim B; Lee JB; Kim JS; Park S; Shin YK
    Vet Microbiol; 2013 Jun; 164(3-4):239-45. PubMed ID: 23490554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C).
    Cao Y; Lu Z; Li D; Fan P; Sun P; Bao H; Fu Y; Li P; Bai X; Chen Y; Xie B; Liu Z
    Vet Microbiol; 2014 Jan; 168(2-4):294-301. PubMed ID: 24345411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine.
    Fernandez-Sainz I; Medina GN; Ramirez-Medina E; Koster MJ; Grubman MJ; de Los Santos T
    Virology; 2017 Feb; 502():123-132. PubMed ID: 28039799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient protection against Asia1 type foot-and-mouth disease using a chimeric vaccine strain suitable for East Asia.
    Ko MK; Jo HE; Choi JH; You SH; Shin SH; Hwang SY; Jo H; Kim HM; Lee MJ; Kim SM; Kim B; Park JH
    Vet Microbiol; 2021 Feb; 253():108975. PubMed ID: 33418393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen.
    Nagendrakumar SB; Srinivasan VA; Madhanmohan M; Yuvaraj S; Parida S; Di Nardo A; Horsington J; Paton DJ
    Vaccine; 2011 Feb; 29(10):1906-12. PubMed ID: 21236232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of viral particle integrity in the serological assessment of foot-and-mouth disease virus vaccine-induced immunity in swine.
    Mansilla FC; Turco CS; Miraglia MC; Bessone FA; Franco R; Pérez-Filgueira M; Sala JM; Capozzo AV
    PLoS One; 2020; 15(5):e0232782. PubMed ID: 32369529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Swine Protection with Three Commercial Foot-and-Mouth Disease Vaccines against Heterologous Challenge with Type A ASIA/G-VII Lineage Viruses.
    Kim SW; Lee SH; Kim HH; Shin SH; Park SH; Park JH; Kim J; Park CK
    Vaccines (Basel); 2024 Apr; 12(5):. PubMed ID: 38793727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.
    Li X; Liu R; Tang H; Jin M; Chen H; Qian P
    Vaccine; 2008 May; 26(22):2714-22. PubMed ID: 18436351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Malaysia 97 monovalent foot-and-mouth disease vaccine (>6PD50/dose) protects pigs against challenge with a variant FMDV A SEA-97 lineage virus, 4 and 7 days post vaccination.
    Nagendrakumar SB; Hong NT; Geoffrey FT; Jacqueline MM; Andrew D; Michelle G; Van Phuc K; Ngon QV; Phuong le TT; Phuc NN; Hanh TX; Van Hung V; Quynhanh le T; Tan TM; Long NT; Wilna V
    Vaccine; 2015 Aug; 33(36):4513-9. PubMed ID: 26192355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.